On June 24, the "Welcome Seminar for International and Mainland Enterprises Settling in Hong Kong" organized by InvestHK was successfully held at the Hong Kong SAR Government Headquarters Building.
As a representative of a key enterprise, Ms. Chan Chau Yuen, General Manager of Hong Kong Electronics Technology Company Limited, was invited to attend the event to discuss the unique value of Hong Kong as an international business hub with nearly 350 senior executives from around the world.
The Chief Executive of the Hong Kong Special Administrative Region (HKSAR), Mr. K.C. Lee, officiated at the Welcome Ceremony and delivered a speech. Mr. Li highly recognized Hong Kong's unique advantages under the "One Country, Two Systems" principle and emphasized its role as the "one country, two systems" linking the Mainland and the world.Super Contacts" and "Super Value-Added PeopleThe central role of "The
He pointed out that Hong Kong has an open and convenient business environment, a long tradition of the rule of law, a simple and low tax policy, and continues to demonstrate strong competitiveness. The Chief Executive said that the HKSAR Government would continue to proactively co-ordinate the needs of various sectors to help enterprises capitalize on Hong Kong's advantages as a multinational supply chain management center and expand their overseas business.Together, we will open up a new blue ocean of development.
Speaking on the occasion, Ms. Rita Lau, Director-General of Investment Promotion (DGIP), said, "Over the past 25 years, InvestHK has been committed to promoting two-way investment exchanges between China and the rest of the world. We have successfully assisted numerous international companies to establish a presence in Hong Kong and expand into the Mainland and Asian markets, and Hong Kong has always been the ideal springboard for Mainland enterprises to go global." Looking ahead, Mr. Lau pledged to continue to promote two-way investment.Connecting Opportunities, Promoting Cooperation, and Creating Long-Term Value for Enterprises".
As a representative of enterprises that have responded positively to the call of Hong Kong's investment environment and successfully developed, Hong Kong Science & Technology has been expanding its global business territory since the establishment of its branch office in Hong Kong in 2011, taking full advantage of Hong Kong's unique business environment and internationalization.
HONGKEI specializes in industrial manufacturing, automotive R&D and testing, providing customers with industrial standard products and one-stop solutions.In 2023, Avision moved into the Data Technology Center of Hong Kong Science Park to further expand its R&D and sales operations in Hong Kong. Our customers in Hong Kong include benchmark organizations such as the Hong Kong MTR, the Hospital Authority and the Chinese University of Hong Kong, and we are one of the leading organizations in the industry.An active practitioner of two-way technology exchange and value transmissionThe
Ms. Chen Qiuyuan, CEO of Hongke, said in the exchange thatHONGKONG is confident about the future development prospects of Hong Kong.Hong Kong's growing competitiveness and global investment attractiveness provide more room for development and more opportunities for cooperation for technology companies like Hong Kong. Hong Kong's growing competitiveness and global investment attractiveness provide technology companies like Hong Kong Science and Technology Parks with more room for development and more opportunities for cooperation.
As always, Hong Kong will continue to be a stronghold of Hong Kong, capitalizing on its unique advantages and working hand in hand with partners from all walks of life.Seize the opportunities in Hong Kong, explore the global blue ocean together, and contribute to the creation of a more prosperous future!
深入解析虹科 GNSS 模擬器如何支援無人機整機測試，涵蓋多星座 GNSS 仿真、RTK 公分級定位、抗干擾測試與多感測器融合驗證，助力高效、安全的 UAV 研發。
增材製造（PBF-LB/M）中的高精度過程監控與誤差檢測，虹科 iDS USB3 工業相機助力粉末層、再熔化層與動態飛濺監控，提升部件品質與研發效率，適用航空航天、醫療、汽車等行業。
虹科與瑞士 ELPRO 長達15年深度合作，提供醫藥供應鏈全流程溫度監測與藥品安全解決方案。探索專業技術、信任合作及生物科技創新，助力中國及亞太市場客戶提升研發效率與藥品安全。
